After erythropoietin (rHuEPO) therapy, patients with chronic renal failure (CRF) do not improve peak O 2 uptake ( O 2 peak) as much as expected from the rise in hemoglobin concentration ([Hb]). In a companion study, we explain this phenomenon by the concurrent effects of fall in muscle blood flow after rHuEPO and abnormal capillary O 2 conductance observed in CRF patients. The latter is likely associated with a poor muscle microcirculatory network and capillary-myofiber dissociation due to uremic myopathy. Herein, cellular bioenergetics and its relationships with muscle O 2 transport, before and after rHuEPO therapy, were examined in eight CRF patients (27 Ϯ 7.3 [SD] yr) studied pre-and post-rHuEPO ([Hb] ϭ 7.8 Ϯ 0.7 vs. 11.7 Ϯ 0.7 g ϫ dl Ϫ 1 ) during an incremental cycling exercise protocol. Eight healthy sedentary subjects (26 Ϯ 3.1 yr) served as controls. We hypothesize that uremic myopathy provokes a cytosolic dysfunction but mitochondrial oxidative capacity is not abnormal.
Introduction
It is known that substantial increases in hemoglobin concentration ([Hb]) 1 after erythropoietin (rHuEPO) therapy in patients with chronic renal failure (CRF) are not followed by corresponding gains of maximum O 2 uptake ( O 2 max) (1-9). In a previous study with CRF patients (10) , O 2 supply dependency of O 2 max was demonstrated. This indicates that peak O 2 is not determined by mitochondrial oxidative limits. The dissociation between increase in [Hb] and the changes of O 2 max after rHuEPO was explained by two factors affecting O 2 transport to the cell.
First, correction of anemia with rHuEPO therapy results in elimination of the hyperdynamic cardiac status. This returns elevated muscle blood flow ( ) to values similar to levels seen in matched control subjects during peak exercise and partially offsets the effect of the rise in arterial O 2 content on O 2 delivery. Second, O 2 conductance from muscle microcirculation to mitochondria is particularly low in CRF patients (10) and after rHuEPO therapy still remains at ‫ف‬ 70% of that seen in control subjects. The structural basis of this abnormal O 2 transport conductance is likely microvascular rarification and capillarymyofiber dissociation provoked by a uremic myopathy (11) (12) (13) . As a result of these changes, the ratio of muscle diffusive to perfusive conductance as defined by Piiper et al. (14) (15) (16) may either not vary (10) or even fall after rHuEPO. Since this Q .
V .
V . [PCr] recovery after exercise, is below the values observed in normal sedentary subjects. This defect in muscle cell bioenergetics may be explained by a cytosolic dysfunction provoked by uremic myopathy. Since evidence of normal mitochondrial oxidative capacity in CRF patients has been reported (11, 18) , and the companion study showed that O 2 peak is O 2 supply dependent in these rHuEPO treated patients, changes in muscle bioenergetics at maximum exercise after rHuEPO therapy must follow those of maximal O 2 flow from muscle capillary to mitochondria. However, different reports examining muscle cell bioenergetics in these patients provide conflicting results (18) (19) (20) (21) (22) . The primary aim of the present study was the analysis of the relationships between muscle O 2 transport and cellular bioenergetics, assessed by 31 P-nuclear magnetic resonance spectroscopy ( 31 P-MRS), before and after erythropoietin therapy. Post-rHuEPO data were compared with those obtained in healthy sedentary subjects. Because we were specifically interested in the analysis of muscle O 2 transport and 31 P-MRS data at maximum O 2 , the exercise protocol was set to explore exercise performance above 70% whole-body O 2 peak.
Methods
Patients. Eight anemic subjects (age 27 Ϯ 7.3 [mean Ϯ SD] yr), seven men and one woman, with chronic renal failure undergoing regular hemodialysis for an average of 12 Ϯ 11 mo, were enrolled in the proto-
col and studied pre-and post-rHuEPO therapy. Anthropometric, lung function data, adequacy of hemodialysis, and hemoglobin concentration [Hb] before and after rHuEPO therapy using standard dosage (82 Ϯ 12 UI ϫ kg Ϫ 1 ϫ wk Ϫ 1 ) are listed in Table I . Eight additional healthy sedentary men, selected on the basis of no previous history of regular or even occasional physical exercise above that required for the average daily activities, were also studied once using an identical protocol and were used as a control group (Table I) . All were informed of any risks and discomfort associated with the experiment, and informed consent was obtained in accordance with the Committee on Investigations Involving Human Subjects at the Hospital Clínic, Universitat de Barcelona. None of these subjects were the same individuals examined in the accompanying paper (10).
Exercise protocol. Exercise tests were performed using an ergometer made of nonmagnetic materials conceived to fit into a standard whole body magnet. The system, described in detail in reference 24, allowed flexion and extension of both legs by alternatively pressing two foot pedals connected to a controlled flow resistance hydraulic system while the subject lay supine on the ergometer table. A piezoelectric force transducer (9251A; Kistler Instruments AG, Winterthur, Switzerland) placed inside one of the pedals was used to determine maximum force of contraction (maximal voluntary contraction, MVC) of the leg and to provide an "on line" control of both strength and rate of pedalling during the exercise test. The exercise protocol, performed at 100 cycles ϫ min
, consisted of a maximum of 5 periods of 2 min exercise at workloads of 20, 25, 30, 35 , and 40% of MVC interspersed by resting periods of 2.5 min. Each subject's MVC was calculated as the mean of three measurements. It should be pointed out that the above mentioned percentages of MVC greatly exceed the corresponding values of O 2 . As reported below, the work load at 20% MVC corresponded to a whole-body O 2 value above 70% of maximum. In each exercise test, the peak workload was defined by the inability to maintain for 30 s the rate of pedalling due to exhaustion.
Study design. In each study, the patient exercised breathing room air (F I O 2 ϭ 0.21) on two different days, less than 1 wk apart, using the same ergometer and performing the same exercise protocol. On the V .
V . first day, rest and exercise 31 P-MRS were obtained without catheters. On the second day, the subject followed the identical exercise protocol (in time and load) outside the magnet with three catheters in place to obtain O 2 transport data. One of the catheters was placed in the radial artery of the contralateral side to the arterio-venous fistula to measure PO 2 , PCO 2 , pH, SaO 2 , lactate, and [Hb] in arterial blood. In the femoral venous vein of the left leg, a 7-F catheter was advanced 7 cm into the vessel with the tip distally oriented (16) , and a 2.5-F thermistor was advanced 5 cm proximally. Measurements of femoral venous blood flow by short term steady state thermodilution principle and measurements of the above variables in arterial and femoral venous blood were obtained. All patients were strongly encouraged to maintain the same level of daily physical activity between the preand post-rHuEPO studies despite any improvement in their quality of life. The time elapsed between pre-and post-rHuEPO studies was 4.2Ϯ1 mo. 31 P-MRS measurements. Studies were carried out using a 1.5 T General Electric Signa Advantage System (General Electric, Milwaukee, WI) (160 ϫ 52 cm bore) operating at a frequency of 63.65 and 25.86 MHz for the hydrogen-1 and the phosphorus-31 nucleus, respectively, connected to a Spectroscopy Analysis Workstation SUN 3/470 (Sun Microsystems Inc., Mountain View, CA). Subjects were placed in the magnet in a supine position, head first, and the elliptical distributed capacitance surface coil (14.5 ϫ 6.5 cm), pretuned at the phosphorus resonant frequency, was positioned and fixed over the vastus medialis muscle of the left leg. Then, the MVC was determined and the position of the surface coil was checked with spin-echo T1-weighted images as described in detail in reference 24. Phosphorus-31 In each panel, the three initial workloads correspond to measurements done at 20, 25, and 30% of MVC, which were carried out in all the subjects studied. The highest workload corresponds to the measurements done at peak exercise. Results are expressed as meanϮSEM. spectra were obtained using 180Њ pulses as measured at the center of the coil. A total of 1,024 data points were collected over a spectral width of 2,500 Hz.
Measurements at rest. Four dummy scans plus 128 transients were accumulated for each spectrum with a recycling time of 2 s. Before Fourier transform, a zero filling to 2,048 data points and apodization by exponential multiplication of 3 Hz were applied to the free induction decay. Spectra were manually phased and baseline was corrected using a c-spline function.
Measurements during exercise. After four initial dummy scans, spectra of 8 transients with a repetition time of 2 s (resolution time of 16 s) were continuously recorded being the first spectrum obtained at rest before starting the exercise. Before Fourier transform, manual phase and baseline correction, a zero filling to 2,048 data points and apodization by exponential multiplication of 5 Hz were applied to the free induction decay. For all spectra, the area under each resonance and its chemical shift were obtained after adjusting to pure lorentzian lines by the Marquardt-Levenberg fitting routine. The spectra collected in the resting period between successive workloads were used for analysis, but those collected during the 2 min exercise could not be analyzed because of the movements of the legs. The collection of a new set of spectra was initiated just after the end of the exercise at each workload. (25) . Both the pHi calculated from the first spectrum (8 s) after cessation of exercise and that corresponding to the nadir during the recovery period were analyzed.
O 2 transport measurements. Subject preparation, safety precautions, and technical aspects of the measurement of femoral venous blood gases and blood flow have been described in detail previously (10, 16, 26) . On-line calculations of whole-body O 2 uptake ( O 2 ), CO 2 output, minute ventilation, respiratory exchange ratio, heart rate, and respiratory rate were averaged sequentially over 15 s intervals and then displayed on a screen monitor to observe the progress of the tests. In each test, measurements were made at rest and during the second min at each workload. In each instance the following measurements were made: (a) PO 2 , PCO 2 , pH (IL model 1302, pH/Blood gas analyzer and tonometer model 237; Instrumentation Laboratories, Milan, Italy), oxyhemoglobin saturation, hemoglobin concentration ([Hb]) (IL 482 co-oximeter), and blood lactate concentrations (YSI 23L blood lactate analyzer; Yellow Springs Instruments, Yellow Springs, OH) from simultaneous arterial and femoral venous blood samples; and (b) femoral venous blood flow ( leg) by thermodilution and arterial pressure. Calculations of the variables have been previously reported in detail in reference 10. Data analysis. Results are expressed as meanϮSD. After rHuEPO, changes in leg were compared using an analysis of covariance after demonstrating existence of a linear relationship between leg and whole-body O 2 (as work rate was increased) with no variations in the slope from pre-to post-rHuEPO. Comparisons between pre-and post-rHuEPO studies were done using Student paired t test, and those between post-rHuEPO and the control group of healthy sedentary subjects were carried out using Student unpaired t test. Unless otherwise stated, comparisons of submaximal exercise were done using pooled data. Statistical significance was set at P Յ 0.05.
Results
Anthropometric data, age, lung function, and changes in [Hb] in the eight CRF patients and the corresponding data from the eight controls are indicated in Table I uptake; pre-post, probability of the comparisons between pre and post-rHuEPO measurements at peak exercise (paired analysis); post-con, probability of the comparisons between post-rHuEPO study and sedentary control subjects at peak exercise (unpaired analysis).
than in controls (68Ϯ8.2 and 76Ϯ6.1%, respectively) (P ϭ 0.05). The combined effects of O 2 leg and O 2 ER on O 2 uptake explain how peak O 2 leg in CRF patients post-rHuEPO was 28% lower than that observed in controls (7.2Ϯ1.4 and 10.0Ϯ1.6 ml ϫ kg Ϫ1 ϫ min
Ϫ1
, respectively) (P ϭ 0.002).
Discussion
Main findings. The present study confirms our previous results (10) (Fig. 3) or that corresponding to the nadir during the recovery period.
Relationships between intracellular pH and femoral venous pH. No differences in femoral venous pH (pH fv ), at a given O 2 leg, were observed between pre-and post-rHuEPO studies. As depicted in Fig. 4 (right) , intracellular and femoral venous pH track each other in all three groups.
Effects of rHuEPO therapy on muscle O 2 transport. Arterial O 2 content (CaO 2 ) increased by 50% (P Ͻ 0.001), parallel to the rise observed in [Hb] (Table II) . However, femoral venous blood flow ( leg) was consistently lower (Ϫ20%) at each workload after rHuEPO (P Ͻ 0.04) (Fig. 5) . The reduction in leg largely offset the effect of the increase in CaO 2 on O 2 delivery ( O 2 leg). At peak exercise, O 2 leg did not change significantly after rHuEPO, the mean value increasing by 17%.
We confirmed existence of a low muscle O 2 conductance (DO 2 ) in CRF patients as previously seen (10), but no increase in DO 2 after rHuEPO was found (10.9 Ϯ 4.2 and 10.9 Ϯ 2.6 ml ϫ mmHg Ϫ1 ϫ min
Ϫ1
, pre-and post-rHuEPO, respectively). As indicated in Table II , one-leg O 2 extraction ratio (O 2 ER) decreased after rHuEPO therapy at each workload. At maximum exercise, O 2 ER fell from 73Ϯ4.0 to 68Ϯ8.2% (P ϭ 0.03). Consequently, the 17% increase in O 2 leg was counterbalanced by the 7% drop in O 2 ER such that both O 2 leg (Table  II) and whole-body O 2 (Table III) did not change significantly (only ϩ8 and ϩ6%, respectively) after rHuEPO therapy.
Comparison of muscle O 2 transport at peak exercise between post-rHuEPO and controls. Muscle O 2 transport variables at peak exercise expressed as percent of the values obtained in the control subjects are shown in Fig. 6 (meanϮSEM). Both [Hb] and CaO 2 in the CRF patients postrHuEPO were ‫ف‬ 18% lower than the corresponding values in the control group, whereas peak leg was similar (65Ϯ1.1 vs. 67Ϯ1.2 ml ϫ kg Ϫ1 ϫ min
, post-rHuEPO and controls respectively). Consequently, O 2 leg was ‫ف‬ 20% lower in CRF patients post-rHuEPO. As expected from the low muscle O 2 conductance in CRF patients, O 2 ER after rHuEPO was also lower Figure 5 . Relationships between femoral venous blood flow ( leg), expressed in ml ϫ kg Ϫ1 ϫ min Ϫ1 (y-axis) and whole-body O 2 uptake, expressed in ml ϫ kg Ϫ1 ϫ min Ϫ1 (x-axis). At any given O 2 , leg significantly decreased after rHuEPO. No differences were detected between the post-rHuEPO and controls. Results are expressed as meanϮSEM.Q VQ we assume that supply dependency was also the case in the present patient group.
The second major finding was that the 31 P-MRS results (Fig. 2) ] on the creatine kinase reaction such that PCr levels no longer strictly depend on changes in ADP concentration. Low pHi can also inhibit adenosinetriphosphatase rates and lower oxidative capacity (29) . The behavior of these energetic indices as a function of pHi suggests that the 31 P-MRS abnormalities may be primarily due to [H ϩ ]-related cytosolic effects on the regulation of the processes involved in [PCr] breakdown and resynthesis rather than to a primary disturbance of the mitochondrial oxidative capacity (30, 31) . The marked differences in pHi between patients and controls, at a given O 2 leg, may be in larger part explained by different lactate levels (Table III) , although without intracellular lactate concentrations this is somewhat speculative. The slightly lower [Hb] (Table I) Results expressed as meanϮSD; 20, 25 and 30% MVC, correspond to the submaximal workloads carried out in all the subjects (actual values of each of these workloads expressed in watts are indicated in this table); peak exercise, measurements obtained at exhaustion; Pre-rHuEPO, Post-rHuEPO, and Control, results before rHuEPO therapy, post-rHuEPO therapy, and from the sedentary control subjects respectively; Watts, workload at each exercise step expressed in watts; O 2 , O 2 uptake; HR, heart rate; [Lact] a , lactage concentration in arterial blood expressed in mM; pre-post, probability of the comparisons between pre and post-rHuEPO measurements at peak exercise (paired analysis); post-con, probability of the comparisons between post-rHuEPO study and sedentary control subjects at peak exercise (unpaired analysis).
V .
V .
Structural and histochemical findings in skeletal muscle biopsies obtained in CRF patents (11) (12) (13) indicate poor capillary network and capillary-myofiber dissociation as the foremost characteristic findings, but also myopathic changes that could decrease oxygen-dependent metabolism. Abnormal oxidative capacity is claimed to exist in CRF patients by some authors (19) . Diesel et al. (13) also argued for a reduced muscle oxidative capacity in CRF patients but these authors used an inadequate control group consisting of trained athletes rather than sedentary subjects. In contrast, Moore et al. (18) suggest preserved intrinsic oxidative mitochondrial capacity in dialysis patients as compared to transplant recipients and healthy subjects, based on their similar post-exercise recovery of [PCr]/ [Pi] ratio and pHi to baseline energy status. The present study provides two new insights compared to the work done by Moore et al. (18) . First, we examine the effects of a marked increase in [Hb] after rHuEPO therapy (by 50%) on muscle bioenergetics. Second, in the present study interpretation of energetic status of the cell (both in the comparison between pre-and post-rHuEPO therapy and in the analysis of the differences between CRF patients post-rHuEPO and healthy sedentary controls) was done, for the first time, using actual muscle O 2 transport and O 2 uptake data obtained while the subject was performing identical exercise protocol and using the same ergometer. Hence, unnecessary assumptions and uncertainties such as the nature of static and dynamic hand-grip exercise (18) can be avoided.
Differences in O 2 transport response to rHuEPO between the present study and reference 10. Despite the marked increase in [Hb] in both investigations (50 and 69%, present study and reference 10, respectively), the weak O 2 transport response after rHuEPO in the present protocol was indeed more evident. The fall in leg after rHuEPO was slightly greater than that seen in reference 10, and at variance with the previous study, muscle oxygen extraction ratio (O 2 ER) significantly decreased after rHuEPO. These two phenomena can account for the lack of change in one-leg O 2 uptake at peak exercise after rHuEPO. A similar lack of response to the rHuEPO therapy was also found in whole-body O 2 uptake at peak exercise which, as indicated in Methods, is a fully independent measurement from one-leg O 2 ( O 2 leg). Since all measurements were done while subjects were breathing room air only, DO 2 in this study is analyzed subject to the assumption of O 2 supply dependency which was demonstrated in reference 10 . The technical requirements to estimate muscle O 2 conductance have been analyzed in detail elsewhere (10, 16, (32) (33) (34) (35) . However, it is of note that post-rHuEPO DO 2 in these patients (10.9Ϯ1.6 ml ϫ mmHg Ϫ1 ϫ min
Ϫ1
) was ‫ف‬ 60% of that obtained in controls (18.2Ϯ3.5 ml ϫ mmHg Ϫ1 ϫ min
). As suggested by Piiper et al. (14) and shown elsewhere (10, 16) , the observed reduction of the O 2 ER after rHuEPO from 73Ϯ4.0 to 68Ϯ8.2% (P Ͻ 0.03) necessarily requires a decrease in diffusional to perfusional conductance ratio (DO 2 /␤ ϫ leg) after rHuEPO. The term ␤ corresponds to the slope of the O 2 dissociation curve and is the ratio of the arterial to femoral venous O 2 content difference and the arterial to femoral venous
The above described differences in muscle O 2 transport between these two investigations (present study and 10), as well as the lack of change in DO 2 after rHuEPO in the present study, can be ascribed to the combined effects of two factors: (a) the smaller increase in [Hb] after rHuEPO in this studẏ Q V .
V
.Q compared to reference 10 (50 vs. 69%, respectively); and (b) the larger reduction in peak leg after rHuEPO in the present investigation (by Ϫ20%, from 82 to 65 ml ϫ kg Ϫ1 ϫ min Ϫ1 ) compared to that observed in reference 10 (by Ϫ13%, from 84 to 73 ml ϫ kg Ϫ1 ϫ min
Ϫ1
). The two groups of CRF patients showed a similar exercise performance (relationships between O 2 and work rate and peak O 2 ), evaluated using a regular cycloergometer (post-rHuEPO whole-body O 2 max, 30.6Ϯ6.6 and 33.1Ϯ4.7 ml ϫ kg Ϫ1 ϫ min
, present study and reference 10, respectively). The present study and reference 10 were performed at the same time using identical inclusion criteria. 31 P-MRS data at rest. Differences of resting [PCr]/[Pi] ratios have been reported among normal sedentary subjects, sprinters, and long-distance runners (36) , likely reflecting different bioenergetic status associated with differences in muscle fiber-type composition. However, a low [PCr]/[Pi] ratio at rest is a characteristic feature of several different metabolic myopathies (37, 38). In the present study, pre-rHuEPO results were below (P ϭ 0.01) those seen in the control group with no significant changes after rHuEPO, indicating a lower muscle energetic status in CRF patients (pre-and post-rHuEPO). We suggest this is probably due to uremic myopathy, rather than related to an abnormal O 2 supply to mitochondria which, at rest, can be assumed largely above cellular O 2 demand. Lower Exercise protocol. We focused the study on the analysis of the relationships between muscle O 2 transport and cellular bioenergetics at maximum exercise. Consequently, the exercise protocol was specifically designed to examine the performance above 70% whole-body O 2 peak. Recall that the percentages of maximal voluntary contraction (%MVC), reported in Tables II and III , greatly exceed the corresponding percentages of whole-body O 2 peak. The marked changes in pHi throughout exercise observed in all the groups (Fig. 2 , bottom right) might constrain the analysis of changes in [PCr]/[Pi] ratio, %[PCr] consumption, and half-time of [PCr] recovery as markers of mitochondrial oxidative capacity. The latter is often explored using submaximal exercise protocols that provoke negligible changes in pHi. To cope with this potential limitation in the interpretation of the results, the 31 P-MRS data were also expressed as a function of pHi, as indicated in Fig. 3 and discussed below. An interesting finding of the present study is the strong correlation between femoral venous pH and pHi in the three groups (Fig. 4) . Moreover, to reach high intensity levels of exercise, the protocol was set at 100 cycles ϫ min Ϫ1 which, in turn, precluded the analysis of the spectra during the leg movements. As indicated in Methods, the PCr and Pi data were extrapolated to time 0 after each work load, and the derived variables Effects of rHuEPO on muscle cell bioenergetics during exercise. The analysis of submaximal and peak exercise data ( Fig. 2) P-MRS data, at a given VO 2 leg, suggests that either: (a) biochemical pathways (i.e., mitochondrial oxidative capacity) not related to O 2 supply to the cell may determine the bioenergetic status of the muscle cells in these patients; or (b) that rHuEPO, despite the marked increase in [Hb] (by 50%), did not effectively increase maximal O 2 flow to the myocytes. The latter is the most likely explanation for the 31 P-MRS data depicted in Fig. 2 as described above. The lack of changes in muscle O 2 transport after rHuEPO are consistent with this notion. Moreover, since O 2 supply dependency of maximum O 2 uptake in CRF patients was demonstrated in the companion study (10) , a reduced oxidative capacity appears unlikely to explain the lack of changes in muscle cell bioenergetics after rHuEPO. Thompson et al. (18) have reported 31 P-MRS data measured in three CRF patients studied pre-and postrHuEPO therapy. These authors suggest that both impaired muscle O 2 transport and limited mitochondrial oxidative capacity play a role limiting maximum exercise performance in these patients. However, the lack of a parallel assessment of muscle O 2 transport in their study limits the interpretation of their results.
In summary, the present study confirms that: (a) reduction in muscle blood flow and (b) abnormal intramuscular O 2 transport due to functional and structural derangement of muscle microcirculation provoked by uremic myopathy can explain the poor peak O 2 leg response after rHuEPO therapy. The lower pHi, at a given O 2 leg, seen in CRF patients compared to controls, may be also partially explained by the low capillarity associated to uremic myopathy. This low pHi seems to account for the lower [PCr]/[Pi] ratio and the longer half-time of {PCr] recovery, at a given O 2 leg, seen in these patients. However, derangement of the cytosolic regulation of oxidative phosphorylation directly provoked by uremic myopathy can not be ruled out.
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